226 related articles for article (PubMed ID: 8755607)
1. Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator.
McNicholas CM; Guggino WB; Schwiebert EM; Hebert SC; Giebisch G; Egan ME
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):8083-8. PubMed ID: 8755607
[TBL] [Abstract][Full Text] [Related]
2. A functional CFTR-NBF1 is required for ROMK2-CFTR interaction.
McNicholas CM; Nason MW; Guggino WB; Schwiebert EM; Hebert SC; Giebisch G; Egan ME
Am J Physiol; 1997 Nov; 273(5):F843-8. PubMed ID: 9374850
[TBL] [Abstract][Full Text] [Related]
3. Rat homolog of sulfonylurea receptor 2B determines glibenclamide sensitivity of ROMK2 in Xenopus laevis oocyte.
Tanemoto M; Vanoye CG; Dong K; Welch R; Abe T; Hebert SC; Xu JZ
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F659-66. PubMed ID: 10751228
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis transmembrane conductance regulator mediates sulphonylurea block of the inwardly rectifying K+ channel Kir6.1.
Ishida-Takahashi A; Otani H; Takahashi C; Washizuka T; Tsuji K; Noda M; Horie M; Sasayama S
J Physiol; 1998 Apr; 508 ( Pt 1)(Pt 1):23-30. PubMed ID: 9490811
[TBL] [Abstract][Full Text] [Related]
5. Identification of the cystic fibrosis transmembrane conductance regulator domains that are important for interactions with ROMK2.
Cahill P; Nason MW; Ambrose C; Yao TY; Thomas P; Egan ME
J Biol Chem; 2000 Jun; 275(22):16697-701. PubMed ID: 10748197
[TBL] [Abstract][Full Text] [Related]
6. CFTR is required for PKA-regulated ATP sensitivity of Kir1.1 potassium channels in mouse kidney.
Lu M; Leng Q; Egan ME; Caplan MJ; Boulpaep EL; Giebisch GH; Hebert SC
J Clin Invest; 2006 Mar; 116(3):797-807. PubMed ID: 16470247
[TBL] [Abstract][Full Text] [Related]
7. The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel.
Schreiber R; Hopf A; Mall M; Greger R; Kunzelmann K
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5310-5. PubMed ID: 10220462
[TBL] [Abstract][Full Text] [Related]
8. Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents.
Sheppard DN; Welsh MJ
J Gen Physiol; 1992 Oct; 100(4):573-91. PubMed ID: 1281220
[TBL] [Abstract][Full Text] [Related]
9. Sulfonylurea receptors inhibit the epithelial sodium channel (ENaC) by reducing surface expression.
Konstas AA; Bielfeld-Ackermann A; Korbmacher C
Pflugers Arch; 2001 Aug; 442(5):752-61. PubMed ID: 11512032
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of the CFTR chloride channel by suramin.
Bachmann A; Russ U; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):473-6. PubMed ID: 10551285
[TBL] [Abstract][Full Text] [Related]
11. Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-regulated apical chloride channels in cortical collecting duct.
Lu M; Dong K; Egan ME; Giebisch GH; Boulpaep EL; Hebert SC
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6082-7. PubMed ID: 20231442
[TBL] [Abstract][Full Text] [Related]
12. Chloride channel and chloride conductance regulator domains of CFTR, the cystic fibrosis transmembrane conductance regulator.
Schwiebert EM; Morales MM; Devidas S; Egan ME; Guggino WB
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2674-9. PubMed ID: 9482946
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis transmembrane conductance regulator-dependent up-regulation of Kir1.1 (ROMK) renal K+ channels by the epithelial sodium channel.
Konstas AA; Koch JP; Tucker SJ; Korbmacher C
J Biol Chem; 2002 Jul; 277(28):25377-84. PubMed ID: 11994290
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a murine cell line.
Sheppard DN; Robinson KA
J Physiol; 1997 Sep; 503 ( Pt 2)(Pt 2):333-46. PubMed ID: 9306276
[TBL] [Abstract][Full Text] [Related]
15. FLAG epitope positioned in an external loop preserves normal biophysical properties of CFTR.
Schultz BD; Takahashi A; Liu C; Frizzell RA; Howard M
Am J Physiol; 1997 Dec; 273(6):C2080-9. PubMed ID: 9435515
[TBL] [Abstract][Full Text] [Related]
16. Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism.
Spirlì C; Fiorotto R; Song L; Santos-Sacchi J; Okolicsanyi L; Masier S; Rocchi L; Vairetti MP; De Bernard M; Melero S; Pozzan T; Strazzabosco M
Gastroenterology; 2005 Jul; 129(1):220-33. PubMed ID: 16012949
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-activated Cl- channels can substitute for CFTR in stimulation of pancreatic duct bicarbonate secretion.
Zsembery A; Strazzabosco M; Graf J
FASEB J; 2000 Nov; 14(14):2345-56. PubMed ID: 11053257
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic sensitivity of Kir1.1 (ROMK) to glibenclamide in the absence of SUR2B. Implications for the identity of the renal ATP-regulated secretory K+ channel.
Konstas AA; Dabrowski M; Korbmacher C; Tucker SJ
J Biol Chem; 2002 Jun; 277(24):21346-51. PubMed ID: 11927600
[TBL] [Abstract][Full Text] [Related]
19. Novel subunit composition of a renal epithelial KATP channel.
Ruknudin A; Schulze DH; Sullivan SK; Lederer WJ; Welling PA
J Biol Chem; 1998 Jun; 273(23):14165-71. PubMed ID: 9603917
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
Stephan D; Winkler M; Kühner P; Russ U; Quast U
Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
